FDA Approves the Biosimilar Hadlima (Adalimumab-bwwd) Michele B. Kaufman, PharmD, BCGP | September 16, 2019Hadlima (adalimumab-bwwd), which is biosimilar to adalimumab, is now FDA approved to treat multiple autoimmune diseases…